With over 30 years in academia and industry, I lead collaborations that bridge foundational chemistry with pharmaceutical development. My expertise focuses on immune-responsive scaffolds and localized, sustained delivery platforms. I am open to high-impact partnerships that translate complex drug delivery systems into patient-ready technologies.